This episode of This Week in Virology discusses three main topics. It begins with a critical look at a politically motivated change to the US CDC's website, which now suggests a link between vaccines and autism cannot be ruled out—a statement the hosts dismiss as anti-scientific. The main segment reviews two papers. The first is the 1953 Watson and Crick paper on DNA structure, which is praised for its clarity but heavily criticized for its lack of original experiments and its reliance on the uncredited data of Rosalind Franklin and Maurice Wilkins. The second paper, from 2025, provides a mechanistic link between Epstein-Barr Virus (EBV) and Systemic Lupus Erythematosus (SLE). Using a novel single-cell sequencing technique, the study shows that in SLE patients, EBV preferentially infects autoreactive B cells and reprograms them into potent antigen-presenting cells, which then drive the systemic autoimmune response.
A Look at DNA's Past and an Autoimmune Future
3:31 CDC Website Change: The hosts discuss an update to the US CDC's website stating a link between vaccines and autism "cannot be ruled out."
They attribute this to political influence from RFK Jr. and call it dangerous misinformation, citing over 40 studies covering 5.6 million people that show no such link.
The premise is logically flawed, as you cannot prove a negative.
7:34 Watson & Crick's 1953 DNA Paper: The panel analyzes the landmark one-page paper from Nature.
The Model: It proposed a double helix with a sugar-phosphate backbone on the outside and specific base pairings (A-T, G-C) on the inside. This immediately suggested a copying mechanism for genetic material.
No Original Data: As far as I can tell, the paper contains no original experiments. It is entirely a work of model-building based on others' findings.
Writing: The paper is commended for its brevity, clarity, and directness, which contrasts sharply with the jargon-heavy papers from Franklin and Wilkins published in the same issue.
14:51 The Rosalind Franklin Controversy: The discussion details the history behind the discovery.
Watson and Crick's model was heavily dependent on data from Rosalind Franklin, particularly her "Photograph 51" and a report on DNA's C2 symmetry, which were shown to them without her permission.
Recent historical analysis suggests Franklin was an equal contributor, not a "wronged heroine" who failed to understand her data, and was sidelined by the era's sexism and Watson's self-serving narrative in his book The Double Helix.
35:42 Epstein-Barr Virus and Lupus (SLE): The main discussion focuses on a 2025 paper linking EBV to lupus.
Background: An epidemiological link between EBV and SLE was known, but the mechanism was a mystery, largely because EBV-infected B cells are extremely rare (~3-4 per million).
New Technology: The study developed a specific single-cell RNA sequencing method ("EBV-Seq") to isolate and analyze these rare cells.
SLE patients have a ~25-fold higher frequency of EBV-infected B cells in their blood compared to healthy controls.
Crucially, in SLE patients, EBV infects B cells that are autoreactive (i.e., they make antibodies against the body's own nuclear proteins). In healthy controls, EBV appears to infect random B cells.
The proposed model is that SLE develops from an unlucky event: in a predisposed individual, EBV happens to infect an autoreactive B cell clone.
This reprogrammed B cell then activates T-helper cells, which in turn stimulate uninfected autoreactive B cells to produce autoantibodies, leading to systemic disease in a process called epitope spreading.
This mechanism explains why standard B cell depletion therapies like Rituximab often fail in SLE—they aren't thorough enough.
Deeper B cell depletion, such as with CD19-targeted CAR-T therapy, has shown success in achieving long-term remission, likely by eliminating this reservoir of virus-reprogrammed cells. An EBV vaccine could potentially prevent this and other autoimmune diseases.